May 26, 2023 – In the fourth quarter of the previous year, Commonwealth Equity Services LLC made an investment in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by purchasing a new stake. The fund allocated $601,000 to acquire 7,308 shares of ACHC’s stock, as stated in its most recent 13F filing with the Securities and Exchange Commission.
Acadia Healthcare is a leading provider of behavioral healthcare services that operates a network of psychiatric hospitals, residential treatment centers for children and adolescents with severe behavioral disorders, substance abuse treatment facilities, and outpatient clinics across the United States and the United Kingdom.
On February 27th of this year, Acadia Healthcare released its earnings results that reflected $0.70 earnings per share (EPS) for the quarter. Analysis showed that they missed the consensus estimate by ($0.04). Nonetheless, it is notable that Acadia Healthcare had a return on equity of 10.22% and net margin of 10.32%, which are impressive indicators to note.
Throughout this year analysts anticipate that Acadia Healthcare will post an EPS of 3.23 from their revenue projection worth $675.30 million for the quarter versus analyst estimates valued at $659.17 million.
The conviction demonstrated by Commonwealth Equity Services LLC through their recent investment is indicative of ACHC’s stable performance in various markets over time together with sound management strategies on financial metrics such as net margins and return on equity.
For those interested in other investments courtesy of hedge funds or insider trading information concerning ACHC visit HoldingsChannel.com to access accurate up-to-date information to ensure informed decision-making regarding your investment endeavors in these uncertain times.
Institutional Investors Show Growing Interest in Acadia Healthcare Company, Inc.
Acadia Healthcare Company, Inc. (ACHC) has recently witnessed a surge in institutional investments with several hedge funds increasing their stakes in the company. SG Americas Securities LLC raised its stake in Acadia Healthcare by 156.7% during Q4 of the previous year and now owns 19,501 shares worth $1,605,000 after buying an additional 11,903 shares. Similarly, Oliver Luxxe Assets LLC grew its stake by 2.7% to own 10,810 shares valued at $890,000 while Mount Yale Investment Advisors LLC raised its stake by 50.4% to own 9,643 shares valued at $754,000 after buying an additional 3,232 shares in Q3 of last year. Frontier Capital Management Co. LLC also grew its stake by 3.7%, owning 388,984 shares worth $30,411,000 after purchasing an additional 13,908 shares while Clough Capital Partners L.P increased its shares by 15.3% to own 21,060 worth $1,6460 million after acquiring an additional 2,800 shares.
This rise in investment brings the current percentage of ACHC stock owned by institutional investors to a remarkable figure of almost 100%. Shares of ACHC opened on Friday at $67.86 and continue to display strong financials with a market cap of $6.25 billion and noteworthy ratios such as P/E ratio of 22:25 and PEG ratio of 1.54.
In their recent comments on ACHC stock holdings Credit Suisse Group rates it high with a price objective on Thursday May at $95 while Mizuho gave it a “neutral” rating for the company with target price set at $80 following Cantor Fitzgerald’s initiation coverage which rated ACHC as “neutral” with target price set at &83.
The US Facilities segment of Acadia Healthcare provides behavioral healthcare services through acute inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers and outpatient community-based services with recent hike in investment indicating growing confidence and interest for future performance among existing institutional investors. It is evident that the uptick in their stocks as a result of this increased investment will drive the organization to further heights.
Discussion about this post